Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Mazor Robotics secures purchase orders for 21 systems in fourth quarter 2016

Mazor Robotics, a pioneer and a leader in the field of surgical guidance systems, received purchase orders for 21 systems during the fourth quarter ended December 31, 2016.

The system orders included four Mazor X trade-in orders from customers who had previously purchased new Renaissance system.

System orders for the fourth quarter increased 75% percent over the prior year period. For the 2016 full year, the Company received orders for a record 62 systems, representing a 138% increase compared to 2015.

“This is the most successful year in Mazor’s history as we set records for systems orders, utilization, and total revenue,” commented Ori Hadomi, Chief Executive Officer.

“Additionally, the commercial partnership with Medtronic and the market launch of the Mazor X system have favorably shifted our growth trajectory. We are positioned for continued success and accelerating market penetration.”

The 21 system purchase orders during the quarter included 19 orders in the U.S. market and two in the International market. In the U.S., 16 system orders are for the Mazor X system and three are for the Renaissance system.

Mazor ended the fourth quarter with a backlog of 21 systems out of which four are trade-in orders, six are units to be delivered to Medtronic as part of the previously announced Q3 Purchase Order and the remaining systems were ordered by new customers. The Company expects to deliver these systems in 2017.

As previously reported, in July the Company implemented a policy enabling U.S. Renaissance system customers to trade-in the Renaissance system for the Mazor X following its commercial launch, which occurred on October 28, 2016.

Revenue from new system sales with the trade-in option will be deferred until the Mazor X orders are supplied or the trade-in option expires. Therefore, the Company expects total fourth quarter revenue, including system sales and recurring revenues, to be approximately $14 million.

The Company currently intends to report its financial results for the fourth quarter and full year ended December 31, 2016 in late February and will issue a press release with the date, time, dial-in credentials and webcast details.